title: [Prevention of neutropenia during adjuvant taxotere therapy for breast cancer].
authors.forename: A S
authors.initials: AS
authors.lastname: Mochalova
authors.forename: I A
authors.initials: IA
authors.lastname: Koroleva
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D002208:Caproates; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage; D000077143:Docetaxel; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D006401:Hematologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D007970:Leukopenia / Q000517:prevention & control; D008875:Middle Aged; D009367:Neoplasm Staging; D009503:Neutropenia / Q000139:chemically induced / Q000517:prevention & control*; D043823:Taxoids / Q000008:administration & dosage / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D002208:Caproates; D006401:Hematologic Agents; D007093:Imidazoles; D043823:Taxoids; D000077143:Docetaxel; C539419:pentanedioic acid imidazolyl ethanamide; D004317:Doxorubicin; D003520:Cyclophosphamide